L-Carnitine for Anemia in Hemodialysis Patients: A Last Resort

[摘要] In this issue of the Clinical Journal of the American Society of Nephrology, Mercadal and colleagues address whether the biologically active form of carnitine, L-carnitine (LC), offers an adjuvant erythropoietic effect to patients with newly diagnosed ESRD undergoing maintenance hemodialysis (1). Their hypothesis, addressed in the CARNIDIAL trial (NCT 00322322) stems from abundant clinical and bioscientific data that have suggested a multiplicity of salutary effects of LC in the anemia of CKD.

[学科分类] 泌尿医学

[关键词] Bone marrow necrosis;Sickle cell disease;Hyperhemolysis syndrome